The Hôpital Broca is a hospital of the Public Assistance - Paris Hospitals located at 54-56 rue Pascal in the 13th arrondissement of Paris, specializing in clinical gerontology.

During the past decade, Groupe Hospitalier Broca-La Rochefoucauld conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Groupe Hospitalier Broca-La Rochefoucauld" #1 collaborator was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 1 trials as a collaborator and "Janssen Alzheimer Immunotherapy (JAI) Research and Development, LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Groupe Hospitalier Broca-La Rochefoucauld" are "Alzheimer Disease" (4 trials). Many other conditions were trialed in "Groupe Hospitalier Broca-La Rochefoucauld" in a lesser frequency.

Most popular intervention types in "Groupe Hospitalier Broca-La Rochefoucauld" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "bapineuzumab" (2 trials), "placebo" (2 trials), "ACC-001" (1 trials), "ACC-001 + QS-21" (1 trials) and "ACC-001(10µg) + QS21" (1 trials). Other intervention names were less common.

The vast majority of trials in "Groupe Hospitalier Broca-La Rochefoucauld" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Groupe Hospitalier Broca-La Rochefoucauld". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Groupe Hospitalier Broca-La Rochefoucauld, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Groupe Hospitalier Broca-La Rochefoucauld, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".